Venetoclax combined with hypomethylating agents or low-dose cytarabine as induction chemotherapy for patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy: a systematic review and meta-analysis
Yao Qin, Pu Kuang, Ting Liu
Topics & Concepts
MedicineCytarabineVenetoclaxInternal medicineMyeloid leukemiaNeutropeniaFebrile neutropeniaInduction chemotherapyChemotherapyAdverse effectOncologyLeukocytopeniaNauseaLeukemiaGastroenterologyChronic lymphocytic leukemiaAcute Myeloid Leukemia ResearchNeutropenia and Cancer InfectionsMultiple Myeloma Research and Treatments